Managing vitamin D deficiency in inflammatory bowel disease

Research output: Contribution to journalReviewResearchpeer-review


Management of inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is generally cumbersome for patients and is a massive health-economic burden. In recent years, the immunomodulating effects of vitamin D have gained a huge interest in its possible pathogenic influence on the pathophysiology of IBD. Vitamin D deficiency is frequent among patients with IBD. Several clinical studies have pointed to a critical role for vitamin D in ameliorating disease outcomes. Although causation versus correlation unfortunately remains an overwhelming issue in the illusive chicken versus egg debate regarding vitamin D and IBD, here we summarise the latest knowledge of the immunological effects of vitamin D in IBD and recommend from available evidence that physicians regularly monitor serum 25(OH)D levels in patients with IBD. Moreover, we propose an algorithm for optimising vitamin D status in patients with IBD in clinical practice. Awaiting well-powered controlled clinical trials, we consider vitamin D supplementation to be an affordable and widely accessible therapeutic strategy to ameliorate IBD clinical outcomes.

Original languageEnglish
Article number31656565
JournalFrontline Gastroenterology
Issue number4
Pages (from-to)394-400
Number of pages7
Publication statusPublished - 2019

    Research areas

  • biologics, clinical control, inflammatory bowel disease, therapy, vitamin D

Number of downloads are based on statistics from Google Scholar and

No data available

ID: 212562347